C/CPublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Relapse in treatment-naive multiple sclerosis (time to event) compared to the general population.
C/TPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Relapse in treatment-naive multiple sclerosis (time to event).
T/TPublished research associates this genotype with typical/baseline likelihood of Relapse in treatment-naive multiple sclerosis (time to event) — no copies of the reported risk allele.
Annals of neurology · 2021 · PMID 33704824 · open access
Questions about rs11871306
What is rs11871306?
rs11871306 is a single position in the genome, in or near the WNT9B gene. Published research associates it with relapse in treatment-naive multiple sclerosis (time to event). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
What conditions is rs11871306 linked to?
On MyGeneLog this position is linked to Multiple Sclerosis. The research behind each link, and its sources, are set out on that condition page.
Does having rs11871306 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs11871306 come from?
GWAS Catalog, Ann Neurol 2021, PMID:33704824. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.